Key facts: JP Morgan cuts Vera Therapeutics price target to $52; company announces inducement grants
JP Morgan has reduced its price target for Vera Therapeutics from $53.00 to $52.00 per share.1Vera Therapeutics announced inducement grants in accordance with Nasdaq Listing Rule 5635(C)(4).2
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments